Section 6: Education and Research

6ER-002

A COMPARATIVE REVIEW OF THE IMPACT OF THE INTRODUCTION OF ON-SITE MOLECULAR TESTING ON THE MANAGEMENT OF ADULT PATIENTS HOSPITALISED WITH SUSPECTED INFLUENZA VIRUS INFECTION (submitted in 2019)

6ER-001

PCSK9 INHIBITORS: VARIATION IN THE LIPID PROFILE IN A REAL WORLD SETTING (submitted in 2019)

6ER-028

PERCEPTION OF HOSPITAL PHARMACISTS TOWARDS PHARMACOGENETIC TESTING

6ER-027

ABSTRACT WITHDRAWN

6ER-026

PERCEPTION OF A PEER-TO-PEER MENTORING EXPERIENCE WITH EUROPEAN PHARMACY STUDENTS IN A STUDENT-RUN FREE CLINIC

6ER-025

IMPACT OF THE NEW EUROPEAN REGULATION ON CLINICAL TRIALS IN THE ACTIVITY AND DYNAMICS OF RESEARCH ETHICS COMMITTEES FROM CATALONIA

6ER-024

ASPIRIN COMPARED TO ENOXAPARIN OR RIVAROXABAN FOR THE PREVENTION OF VTE FOLLOWING HIP AND KNEE REPLACEMENT – A RETROSPECTIVE COHORT STUDY IN IRELAND

6ER-023

ESTABLISHMENT OF GROUP WORK: WHAT IS THE EFFECT ON THE STATE OF KNOWLEDGE AND PERCEPTION OF PHARMACOVIGILANCE AMONG OUR FUTURE MOROCCAN PHARMACISTS?

6ER-022

WHAT IS PHARMACOVIGILANCE FOR YOU? A SURVEY OF 153 PHARMACISTS

6ER-021

WHY SUCH A LOW PARTICIPATION OF PHARMACISTS IN THE PATIENT EDUCATION PROGRAMMS IN OUR HOSPITAL?

6ER-020

SOCIAL AUTHORITIES CONCERNING #HOSPITALPHARMACY ON TWITTER

6ER-019

INTRODUCING YOUNG HOSPITAL PHARMACISTS TO SCIENTIFIC RESEARCH: AN EDUCATIONAL PROJECT SUPPORTED BY A NATIONAL SOCIETY FOR CLINICAL PHARMACY

6ER-018

DEVELOPMENT AND PERFORMANCE EVALUATION OF THE MEDICINES OPTIMISATION ASSESSMENT TOO: A PROGNOSTIC MODEL TO TARGET HOSPITAL PHARMACISTS' INPUT TO PREVENT MEDICATION-RELATED PROBLEMS

6ER-017

ABSTRACT WITHDRAWN

6ER-016

CLINICAL TRIALS: THERAPEUTIC OPPORTUNITIES, ECONOMIC IMPACT AND SAVINGS FOR THE NATIONAL HEALTH SYSTEM

Pages